---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-031629"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:21:09.024574+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical Q1 net sales $17.3M (-8% YoY); guides FY26 gross margin 18-22%

## Summary
- Net sales $17.3M, down 8% from $18.9M; net loss $1.6M vs $1.5M in prior year.
- Gross margin improved to 17% from 16%; gross profit $2.9M flat YoY.
- FY26 guidance: net sales $70-75M, gross margin 18-22%, Adj. EBITDA $1-2M, positive op. cash flow.
- Operational changes expected to generate >$3M annualized additional gross profit.
- Cash $23.9M at March 31; final $0.5M Evoqua earnout payment made in April.

## SEC filing metadata
- accession: 0001628280-26-031629
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000162828026031629/0001628280-26-031629-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000162828026031629/rmti-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-031629
- JSON: https://secwatch.observer/filing/0001628280-26-031629.json
- Plain text: https://secwatch.observer/filing/0001628280-26-031629.txt

## Source-grounded claims
- claim_id: 1f44f89dd0153b7f69329e8e153c919f178e12e7
  claim: ROCKWELL MEDICAL, INC. reported fiscal year 2026 results: revenue $70.0M to $75.0M.
  evidence_excerpt: Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828026031629/0001628280-26-031629-index.htm
- claim_id: a50f18bea47fa323695037e7a374fb9f5fefe2de
  claim: ROCKWELL MEDICAL, INC. reported the three months ended March 31, 2026 results: revenue $17.3 million, net income $1.6 million, EPS $(0.04).
  evidence_excerpt: reference in such a filing. --- EX-99.1 (EX-99.1) --- Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability • Reports $17.3 million in net sales, $2.9 million in gross profit, and 17% gross margin in the first quarter 2026. • Announces operational changes that are expected to generate more than $3 million in
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828026031629/0001628280-26-031629-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.